AR127559A1 - COMPOUNDS, COMPOSITIONS AND METHODS - Google Patents
COMPOUNDS, COMPOSITIONS AND METHODSInfo
- Publication number
- AR127559A1 AR127559A1 ARP220103009A ARP220103009A AR127559A1 AR 127559 A1 AR127559 A1 AR 127559A1 AR P220103009 A ARP220103009 A AR P220103009A AR P220103009 A ARP220103009 A AR P220103009A AR 127559 A1 AR127559 A1 AR 127559A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- compounds
- methods
- compound
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de la fórmula (1). Reivindicación 35: Una composición farmacéutica que comprende un compuesto de cualquier reivindicación anterior, o una sal farmacéuticamente aceptable, estereoisómero, mezcla de estereoisómeros o profármaco de este, y un portador farmacéuticamente aceptable.A compound of the formula (1). Claim 35: A pharmaceutical composition comprising a compound of any preceding claim, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers or prodrug thereof, and a pharmaceutically acceptable carrier.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163274916P | 2021-11-02 | 2021-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR127559A1 true AR127559A1 (en) | 2024-02-07 |
Family
ID=84364211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220103009A AR127559A1 (en) | 2021-11-02 | 2022-11-02 | COMPOUNDS, COMPOSITIONS AND METHODS |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR127559A1 (en) |
| TW (1) | TW202334135A (en) |
| WO (1) | WO2023081666A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2499465A1 (en) * | 2002-07-16 | 2004-01-22 | Amura Therapeutics Limited | Biologically active compounds |
| EP1565436B1 (en) * | 2002-11-27 | 2012-04-25 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| WO2012125661A1 (en) * | 2011-03-17 | 2012-09-20 | Merck Sharp & Dohme Corp. | Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists |
-
2022
- 2022-11-01 WO PCT/US2022/079094 patent/WO2023081666A1/en not_active Ceased
- 2022-11-01 TW TW111141572A patent/TW202334135A/en unknown
- 2022-11-02 AR ARP220103009A patent/AR127559A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202334135A (en) | 2023-09-01 |
| WO2023081666A1 (en) | 2023-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20044709A (en) | CARDIAC SARCOMER INHIBITORS | |
| ZA202200519B (en) | Piperidinyl-methyl-purineamines as nsd2 inhibitors and anti-cancer agents | |
| MX2022004451A (en) | HETEROARYL-BIPHENYL-AMIDES FOR THE TREATMENT OF DISEASES RELATED TO THE PD-L1 LIGAND. | |
| AR056873A1 (en) | DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS QUINASA INHIBITORS OF CYCLINE DEPENDENTS, PHARMACEUTICAL COMPOSITIONS | |
| MX2025004220A (en) | Tricyclic compounds and their uses | |
| MX2024009926A (en) | Compositions and methods for treating cns disorders. | |
| MX2020009530A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors. | |
| MX2024003738A (en) | Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compounds. | |
| MX2022004450A (en) | HETEROARYL-BIPHENYL AMINES FOR THE TREATMENT OF PD-L1 DISEASES. | |
| DOP2024000146A (en) | PARP7 INHIBITORS | |
| WO2022104153A3 (en) | Compounds and methods for treating viral infections | |
| MX2024012470A (en) | Cdk9 inhibitors | |
| MX2021003232A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors. | |
| CO2022008616A2 (en) | Oral pharmaceutical composition comprising carbamate compound and method of preparation therefor | |
| EA202192530A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| AR127496A1 (en) | CD73 COMPOUNDS | |
| CR20230218A (en) | New indazole acetylene derivatives | |
| AR127559A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| AR133240A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| AR132818A1 (en) | COMPOUNDS FOR THE DEGRADATION OF EGFR KINASE | |
| AR133241A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| MX2022005199A (en) | SSAO INHIBITORS AND USE THEREOF. | |
| WO2020251871A3 (en) | Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors | |
| MX2024008745A (en) | COMPOUND DERIVED FROM 1,3-BENZODIOXOL AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT. | |
| AR130303A1 (en) | PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR THERAPEUTIC USE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |